Whippany, NJ (June 9 , 2006) - Image Solutions Inc., (ISI) a global technology company and a leader in providing software solutions and services for electronic regulatory document submission and clinical trials management, announced today the release of eCTDXPress Aspire™ -- an “out of the box” eSubmission package designed specifically for growing Biotech and small Pharmaceutical organizations to file electronic submissions such as Investigational New Drugs (INDs), Biologic applications (BLAs), New Drug Applications (NDAs), abbreviated NDA’s (aNDAs), New Drug Submissions (NDS), and Marketing Authorization Applications (MAAs) in the electronic Common Technical Document (eCTD) format.
Oftentimes, smaller, growing biotech and pharmaceutical organizations have limited budgets, Regulatory Operations staff, and IT support required to implement, validate, and maintain an in-house eSubmissions infrastructure. eCTDXPress Aspire™ provides multiple advantages for smaller biotech and pharmaceutical organizations by providing an ability to create and manage submissions in-house and ensure that their system will be professionally implemented and fully validated. Designed for small companies anticipating future growth, eCTDXPress Aspire™ is fully scalable and can be expanded as their company grows. Additional benefits include the ability to manage submission lifecycles, on-site maintenance support from ISI, and the availability of dedicated ISI consultants for regulatory operations submission assistance to ensure a successful pilot and submission. Many of the early adopters of this bundled solution are also finding it to provide an excellent opportunity for their in-house publishing staff to gain valuable knowledge and in-house experience about building submission ready eCTDs in anticipation of upcoming submissions.
Jinsoo Kim, ISI’s CEO states “ISI has always supported the smaller pharma and biotech companies by providing low cost and reliable software and outsourcing solutions for the smaller Life Sciences firms. With the adoption of the the eCTD formatted submissions in the US, Europe, Canada and Japan, we feel this packaged solution is exactly what the smaller pharma and biotech companies need to file successful submissions, backed by ISI’s 14-year submission experience.”
The eCTDXPress Aspire™ package includes eCTDXPress 2.3 software that is fully installed and validated on a server, on-site implementation by ISI, complete eCTDXPress training by ISI, submission and regulatory operations consulting, technical support for eCTDXPress software for one year, onsite maintenance, and on-going assistance by ISI to build the first pilot eCTD and submission. ISI will also provide on site staff augmentation to assist with the submission at the clients’ request.
ISI will conduct a series of educational seminars in July to introduce this new solution in several hotbed biotech regions including San Diego, San Francisco, Seattle, Boston, Maryland, and North Carolina. For more information about these seminars or to register, visit the ISI website www.imagesolutions.com
eCTDXPress® is ISI’s web-based solution for managing, compiling, reviewing, registering, and storing eCTD submissions. Created to satisfy both agency and sponsor needs, eCTDXPress® allows your organization to easily meet the regulatory requirements for eCTD submissions throughout the world, using key features that reduce eCTD submission challenges. eCTDXPressAspire™ includes eCTDXPress® Compiler, Web-based Link Management, and eCTDXPress® Manager. eCTDXPress® Compiler allows publishers to easily create the original eCTD application and maintain the lifecycle updates. Compiler contains many robust features that ensure a submission is built according to the DTD and agency specifications and is extremely useful when building the original eCTD, or providing new sequences to agencies. Many of ISI’s best hyperlinking plug-ins from ISIToolBox Pharma™ have also been incorporated in the Web-based Link Management feature of eCTDXPressAspire™ and finally, eCTDXPress® Manager provides a central repository for all your eCTDs and allows an organization to import, view, and collaborate on the review and internal approval of eCTDs.